Skip to Main Content

Paper Details

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.
Sci Transl Med
47
2022
CD4, CD4 T cells, HIV, HIV sequences, HIV-infected cells, Latently infected cells, PD-1, PLWH, Pembrolizumab, anti-PD-1, cancer, infected cells, latently infected cells, participant, people, plasma HIV RNA, programmed cell death protein 1, programmed cell death protein 1 (PD, sorted blood CD4 T cells, unspliced HIV RNA, unspliced RNA
Author NameAffiliation
Jeffrey D LifsonFrederick National Laboratory for Cancer Research
Rafick-Pierre SekalyEmory University
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Sharon R LewinUniversity of Melbourne at the Peter Doherty Institute for Infection and Immunity
Sharon R LewinRoyal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity
Sharon R LewinAlfred Hospital and Monash University
  • 1 - 7

Datasets

Release 1.2